We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
U.S. Sen. Gary Peters (D-Mich.) sent a letter Wednesday to acting FDA Commissioner Ned Sharpless asking what the agency is doing to curb drug shortages. Read More
Sarepta Therapeutics was “surprised” to receive a complete response letter from the FDA for its new drug application for Vydonos 53 (golodirsen) for treatment of Duchenne muscular dystrophy. Read More
Progressive groups organized a series of rallies across the country Tuesday as part of a “People Over Pharma Profits” day of action. The coalition — dubbed “Lower Drug Prices Now” — includes Public Citizen, Health Care for America Now, Families USA, and MoveOn. The group planned 51 “People Over Pharma Profits” events across 32 states. Read More